The 340B Drug Pricing Program Needs A Big Fix
2 CommentsBy Ed Silverman // September 26th, 2011 // 8:20 am
• Pharma Blog » Archives
General Accountability Office
GAO Denies Problems With Report On FDA’s OCI
1 CommentBy Ed Silverman // December 6th, 2010 // 2:01 pm
Who Was The Mole? GAO Probes Its Own FDA Report
Make a commentBy Ed Silverman // November 30th, 2010 // 10:27 am
FDA Fails To Inspect Foreign Plants Sufficiently: GAO
4 CommentsBy Ed Silverman // November 1st, 2010 // 10:29 am
FDA, An Office Mistress & A Compromised Report
7 CommentsBy Ed Silverman // October 14th, 2010 // 10:27 am
The FDA Is Cracking Down On Non-Inferiority Trials
6 CommentsBy Ed Silverman // August 30th, 2010 // 8:28 am
Specialty Drugs, Medicare D & Catastrophic Coverage
5 CommentsBy Ed Silverman // March 2nd, 2010 // 7:59 am
GAO Finds ‘Extraordinary’ Drug Price Hikes
3 CommentsBy Ed Silverman // January 12th, 2010 // 7:58 am
FDA Fails To Follow-Up On Questionable Drugs
5 CommentsBy Ed Silverman // October 26th, 2009 // 7:24 am